MedTrace Logo

Radiation Therapy in Treating Patients With Aggressive Fibromatoses

NCT00030680 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 44

Last updated 2013-08-27

No results posted yet for this study

Summary

RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells.

PURPOSE: Phase II trial to study the effectiveness of radiation therapy in treating patients who have aggressive fibromatoses.

Conditions

  • Desmoid Tumor

Interventions

RADIATION

radiation therapy

Sponsors & Collaborators

  • European Organisation for Research and Treatment of Cancer - EORTC

    lead NETWORK

Principal Investigators

  • R. B. Keus, MD · Arnhems Radiotherapeutisch Instituut

  • Thomas Schnabel, MD · Klinikum der Stadt Ludwigshafen am Rhein

Study Design

Purpose
TREATMENT

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2001-11-30
Primary Completion
2012-03-31
Completion
2012-03-31

Countries

  • Belgium
  • France
  • Germany
  • Netherlands
  • Poland
  • Switzerland
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00030680 on ClinicalTrials.gov